Artes Medical Sets Terms

Artes Medical Inc., a San Diego-based developer of injectable aesthetic products for the dermatology and plastic surgery markets, set its proposed IPO terms to 4.6 million common shares being offered at between $12 and $14 per share. It plans to trade on the Nasdaq under ticker symbol ARTE, with Cowan & Co. and Lazard Capital Markets serving as co-lead underwriters. The company has raised around $61 million in total VC funding from backers like National Securities Corp., Empire Asset Management, Baltimore Business Leaders, NGN Capital, Peter and Georgia Angelos and Lon Otembra.< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />